Feasibility of peripheral blood progenitor cell harvest and transplantation in patients with poor-risk myelodysplastic syndromes

British Journal of Haematology

Volumn 92, Issue 2, 1996, Pages 351-359

  Demuynck, H ^a   Delforge, M ^a   Verhoef, G E G ^a   Zachee, P ^a   Vandenberghe, P ^a   Van Den Berghe, H ^a   Boogaerts, M A ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Autologous progenitor cell transplantation; Myelodysplastic syndromes

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MITOXANTRONE;

ADULT; ARTICLE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MYELODYSPLASIA; PRIORITY JOURNAL; STEM CELL;

EID: 0030034127     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1479.x     Document Type: Article

References (41)

1. Anderson, J.E., Appelbaum, F.R., Fisher, L.D., Schoch, G., Shulman, H., Anasetti, C., Bensinger, W.I., Bryant, E., Buckner, C.D., Doney, K., Martin, P.J., Sanders, J.E., Sullivan, K.M. & Thomas, E.D. (1993) Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood, 82, 677-681.
2. Anan, K., Ito, M., Misawa, M., Ohe, Y., Kai, S., Kohsaki, M. & Hara, H. (1995) Clonal analysis of peripheral blood and haemopoietic colonies in patients with aplastic anaemia and refractory anaemia using the polymorphic short tandem repeat on the human androgen-receptor (HUMARA) gene. British Journal of Haematology, 89, 838-844.
3. Appelbaum, F.R., Barrall, J., Storb, R., Fisher, L.D., Schoch, G., Ramberg, R.E., Shulman, H., Anasettti, C., Bearman, S.I., Beatty, P., Bensinger, W.I., Buckner, D., Clift, R.A., Hansen J.A., Martin, P., Petersen, F.B., Sanders, J.E., Singer, J., Stewart, P., Sullivan, K.M., Witherspoon, R.P. & Thomas, E.D. (1990) Bone marrow transplantation for patients with myelodysplasia: pretreatment variables and outcome. Annals of Internal Medicine, 112, 590-597.
4. Bearman, S.I., Appelbaum, F.R., Buckner, C.D., Petersen, F.B., Fisher, L.D., Clift, R.A. & Thomas, E.D. (1988) Regimen-related toxicity in patients undergoing bone marrow transplantation. Journal of Clinical Oncology, 6, 1562-1568.
5. Bennett, J.M., Catovsky, D., Daniel, M.T.,. Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
6. Bensinger, W.I., Longin, K., Appelbaum, F., Rowley, S., Weaver, C., Lilleby, K., Gooley, T., Lynch, M., HIgano, T., Klarnet, J., Chauncey, T., Storb, R. & Buckner, C.D. (1994) Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. British Journal of Haematoloay, 87, 825-831.
7. Bird, J.M., Bloxham, D., Samson, D., Marcus, R.E., Russell, N.H., Kelsey, S.M., Newland, A.C. & Apperley, J.E. (1994) Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients. British Journal of Haematology, 88, 110-116.
8. Boogaerts, M.A. (1989) Progress in the therapy of myelodysplastic syndromes. Blut, 58, 265-270.
9. Boogaerts, M.A. & Demuynck, H. (1994) The changing face of stem cell transplantation by the use of recombinant human granulocyte colony stimulating factor. European Journal of Cancer, 30, S34-S39.
10. Carella, A.M., Podesta, M., Frassoni, F., Raffo, M.R., Pollicardo, N., Pungolino, E., Vimercati, R., Sessarego, M., Parodi, C., Rabitti, C., Ferrero, R., Benvenuto, F., Figari, O., Carlier, P., Levcasic, G., Valbonesi, M., Vitale, V., Giordano, D., Pierluigi, D., Nati, S., Guierraçio, A., Rosso, C. & Saglio, G. (1993) Collection of normal blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplantation, 12, 267-271.
11. Delforge, M. Van Duppen, V., Demuynck, H., Verhoef, G.E.G., Vandenberghe, P., Zachée, P. & Boogaerts, M.A. (1995) Polyclonal primitive haematopoietic progenitors can be demonstrated in mobilized PBPC collections of patients with myelodysplastic syndromes. Bone Marrow Transplantation, 15, (Suppl. 2), 46.
12. Demuynck, H., Delforge, M., Verhoef, G.E.G., Zachee, P., Vandenberghe, P. & Boogaerts, M.A. (1995a) Comparative study of peripheral blood progenitor cell collection in patients with multiple myeloma after single dose cyclophosphamide combined with rhGM-CSF or rhG-CSF. British Journal of Haematology, 90, 384-592.
13. Demuynck, H., Pettengell, R., De Campos, E., Dexter, T. & Testa, N. (1992) The capacity of peripheral blood stem cells mobilised with chemotherapy plus G-CSF to repopulate irradiated marrow stroma in vitro is similar to that of bone marrow. European Journal of Cancer, 28, 381-386.
14. Demuynck, H., Verhoef, G.E.G., Zachée, P., van der Schueren, E., Emonds, M.P., van den Berghe, H., Casteels-Van Daele, M. & Boogaerts, M.A. (1995b) Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical siblings and other donors. Bone Marrow Transplantation, in press.
15. De Witte, T., Van Biezen, A., Labopin, M., Hermans, J., Runde, V., Öberg, G., Or, R., Grathwohl, A., Niederwieser, D., Meloni, G., Morgan, G., Apperley, J., Vernant, J., Kolb, U., Vossen, J., Ljungman, P., Beelen, D., Ferrant, A., Arnold, R., Cahn, J., Bacigalupo, A., Fibbe, W. & Gorin, N. (1995) Autologous BMT for patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia following MDS (sAML): a report form the chronic and acute leukemia working parties. Bone Marrow Transplantation, 15, suppl 2, 36.
16. De Witte, T., Zwaan, F., Hermans, J., Vernant, J., Kolb, H., Vossen, J., Lonnqvist, B., Beelen, D., Ferrant, A., Gmür, J., Liu, Y., Troussard, X., Cahn, J., Van Lint, M. & Gratwohl, A. (1990) Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome : a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). British Journal of Haematology, 74, 151-155.
17. Dreger, P., Marquardt, P., Haferlach, T., Jacobs, S., Mulverstedt, T., Eckstein, V., Suttorp, M., Loffler, H., Muller-Ruchholtz, W. & Schmitz, N. (1993) Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product. British Journal of Cancer, 68, 950-957.
18. Gianni, A.M., Siena, S., Bregni, M., Tarella, C., Stern, A., Pileri, A. & Bonadonna, G. (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet, ii, 580-585.
19. Greenberg, P., Taylor, K., Larson, R., Koeffler, P., Negrin, R., Saba, H., Ganser, A., Jakubowski, A., Gabrilove, J., Mufti, G., Cruz, J., Hammond, W., Broudy, V., Langley, G.R., Keating, A., Vardiman, J., Lamborn, K. & Brown, S. (1993) Phase III randomized multicenter trial of G-CSF vs observation for myelodysplastic syndromes. Blood, 82, (Suppl. 1), 196a.
20. Haas, R., Hohaus, S., Egerer, G., Ehrhardt, R., Witt, B. & Hunstein, W. (1992) Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest. Bone Marrow Transplantation, 9, 459-465.
21. Haas, R., Möhle, R., Frühauf, S., Goldschmidt, H., Witt, B., Flentje, M., Wannenmacher, M. & Hunstein, W. (1994) Patient characteristics associated with successful mobilization and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood, 83, 3787-3794.
22. Hoyle, C.F., De Bastos, M., Wheatley, K., Sherrington, P.D., Fischer, P.J., Rees, J.K.H., Gray, R. & Hayhoe, F.G.J. (1989) AML associated with previous cytotoxic therapy, MDS or myloproliferative disorders: results from the MRCs AML trial. British Journal of Haematology, 72, 45-53.
23. Juttner, C.A., To, L.B., Haylock, D.N., Branford, A. & Kimber, R.J. (1985) Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. British Journal of Haematology, 61, 739-745.
24. Juttner, C.A., To, L.B., Ho, J.Q.K., Bardy, P., Dyson, P.G., Haylock, D.N. & Kimber, R.J. (1988) Early lympho-haemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukaemia. Transplantation Proceedings, 20, 40-43.
25. Kernan, N., Bartsch, G., Ash, R., Beatty, P., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J., Henslee-Downey, J., McCulloug, J., McGlave, P., Perkins, H.A., Phillips, G.L., Sanders, J., Stroncek, D., Thomas, E.D. & Blume, K.G. (1993) Analysis of 462 transplants from unrelated donors facilitated by the national marrow donor program. New England Journal of Medicine, 328, 593-602.
26. Kessinger, A., Armitage, J.O., Landmark, J.D., Smith, D.M. & Weisenburger, D. (1988) Autologous peripheral blood hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood, 71, 723-727.
27. Korbling, M., Fliedner, T.M., Holle, R., Magrin, S., Holdermann, E., Eberhardt, K. (1991) Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival. Bone Marrow Transplantation, 7, 343-349.
28. Kotasek, D., Shepherd, K.M., Sage, R.E., Dale, B.M., Norman, J.E., Charles, P., Gregg, A., Pillow, A. & Bolton, A. (1992) Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplantation, 9, 11-17.
29. + cells with a different antigenic profile compared with use during steady-state hematopoiesis. Bone Marrow Transplantation, 14, 827-823.
30. Negrin, R.S., Haeuber, D.H., Nagler, A., Kobayashi, Y., Sklar, J., Donlon, T., Vincent, M. & Greenberg, P.L. (1990) Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood, 76, 36-43.
31. Nevill, T.J., Shepherd, J.D., Reece, D.K., Bernett, M.J., Nantel, S.H., Klingemann, K.G. & Phillips, G.L. (1992) Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMT. Bone Marrow Transplantation, 10, 445-450.
32. Reiffers, J., Stoppa, A.M., Attal, M. & Michallet, M. (1994) Is there a place for blood stem-cell transplantation for the younger adult patient with acute myelogenous leukemia? BGMT Group. (Letter). Journal of Clinical Oncology, 12, 1100-1102.
33. Runde, V., de Witte, T., Gratwohl, A., Niederwieser, D., Van Biezen, A., Hermans, J., Vernant, J., Kolb, H., Vossen, J., Lönqvist, B., Beelen, D., Ferrant, A., Arnold, R., Cahn, J., Van Lint, M., Verdonk, L., Aul, C. & Apperley, J. (1995) Allogeneic bone marrow transplantation (BMT) for patients with myelodysplastic syndromes (MDS) or leukemia following MDS (sAML): a survey for the working party on chronic leukemia of the EBMTG. Bone Marrow Transplantation, 15, (Suppl. 2), 86.
34. Sanz, M.A., de la Rubia, J., Sanz, G.F., Martin, G., Martinez, J., Jarque, I., Sempere, A., Gomis, F., Senent, L., Soler, M.A., Lopez, F., Arilla, M.J., Carpio, N., Guinot, M., Palau, J., Tudela, M. & Marty, M.L. (1993) Busulfan plus cyclophosphamide followed by autologous blood stem cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution. Journal of Clinical Oncology, 11, 1661-1667.
35. Schmitz, N., Linch, D.C., Dreger, P., Boogaerts, M.A., Goldstone, A.H., Ferrant, A., Demuynck, H.M.S., Link, H., Zander, A., Matcham, J., Borkett, K.M. & Schwab, G. (1994) A randomized phase III study of filgrastim-mobilised peripheral blood progenitor cell transplantation (PBPCT) in comparison with autologous bone marrow transplantation (ABMT) in patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). Blood, 84, 204a.
36. Sheridan, W.P., Begley, C.G., Juttner, C.A., Szer, J., To, L.B., Maher, D., McGrath, K.M., Morstyn, G. & Fox, R.M. (1992) Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet, 339, 640-644.
37. Siena, S., Bregni, M., Brando, B., Belli, N., Ravagnani, F., Gandola, L., Stern, A., Lansdorp, P., Bonadonna, G. & Gianni, A. (1991) Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood, 77, 400-409.
38. Sutherland, H., Eaves, C., Eaves, A., Dragowska, W. & Landsdorp, P. (1989) Characterization and partial purification of human marrow cells capable of initiating long-term hemopoiesis in vitro. Blood, 74, 1563-1570.
39. To, L.B., Dyson, P., Branford, A.L., Russell, J.A., Haylock, D.N., Ho, J.Q.K., Kimber, R.J. & Juttner, C.A. (1987) Peripheral blood stem cells collected in very early remission produce rapid and sustained autologous haemopoietic reconstitution in acute non-lymphoblastic leukaemia. Bone Marrow Transplantation, 2, 103-108.
40. Tricot, G. & Boogaerts, M.A. (1986) The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromes. British Journal of Haematology, 63, 477-483.
41. Verhoef, G., De Wolf-Peeters, C., Kerim, S., Van De Brock, J., Mecuccu, C., Van Den Berghe, H. & Boogaerls, M. (1991) Update on the prognostic implication of morphology, histology and karyotype in primary myelodysplastic syndrome. Hematologic Pathology, 5, 163-175.